Royal Liverpool pioneering treatment for rare liver cancer

RESEARCH: Researchers from the Royal Liverpool and Broadgreen University Hospitals Trust Royal have been pioneering an innovative new technique to treat patients with rare liver cancer hepatocellular carcinoma (HCC) that can extend their life expectancy and reduce side effects.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here